Clinically-Relevant Biomarker Strategies in Drug Development

Clinically-Relevant Biomarker Strategies in Drug Development and the Potential of Machine-Learning for Biomarker Assessment, Upcoming Webinar Hosted by Xtalks

Toronto, ON (PRWEB) November 02, 2022 -- Biomarker quantification plays an integral role in the drug development process, providing guidance for downstream

Related Keywords

Vera Kovacevic , Justin Devine , Nicholas Woudberg , Honeycomb Worldwide Inc , Relevant Biomarker Strategies In Drug Development , Synexa Life Sciences , Scientific Engagement , Proposals Manager , Clinically Relevant Biomarker Strategies , Drug Development , Life Science , Press Release ,